These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 39208742)
1. Discovery of novel dihydropyrrolidone-thiadiazole compound crosstalk between the YycG/F two-component regulatory pathway and cell membrane homeostasis to combat methicillin-resistant Staphylococcus aureus. Xiong Y; Wang R; Zheng J; Fang D; He P; Liu S; Lin Z; Chen X; Chen C; Shang Y; Yu Z; Liu X; Han S Eur J Med Chem; 2024 Nov; 277():116770. PubMed ID: 39208742 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of new quinazolin-4(3H)-one derivatives as potent antibacterial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis. Gatadi S; Gour J; Shukla M; Kaul G; Dasgupta A; Madhavi YV; Chopra S; Nanduri S Eur J Med Chem; 2019 Aug; 175():287-308. PubMed ID: 31096152 [TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of unique indole-benzosulfonamide oleanolic acid derivatives as potent antibacterial agents against MRSA. Li J; Sun Y; Su K; Wang X; Deng D; Li X; Liang L; Huang W; Shang X; Wang Y; Zhang Z; Ang S; Wong WL; Wu P; Hong WD Eur J Med Chem; 2024 Oct; 276():116625. PubMed ID: 38991300 [TBL] [Abstract][Full Text] [Related]
5. N-thiadiazole-4-hydroxy-2-quinolone-3-carboxamides bearing heteroaromatic rings as novel antibacterial agents: Design, synthesis, biological evaluation and target identification. Xue W; Li X; Ma G; Zhang H; Chen Y; Kirchmair J; Xia J; Wu S Eur J Med Chem; 2020 Feb; 188():112022. PubMed ID: 31901744 [TBL] [Abstract][Full Text] [Related]
6. Synthesis of 1,2,3-triazole linked 4(3H)-Quinazolinones as potent antibacterial agents against multidrug-resistant Staphylococcus aureus. Gatadi S; Gour J; Shukla M; Kaul G; Das S; Dasgupta A; Malasala S; Borra RS; Madhavi YV; Chopra S; Nanduri S Eur J Med Chem; 2018 Sep; 157():1056-1067. PubMed ID: 30176536 [TBL] [Abstract][Full Text] [Related]
7. Membrane-active amino acid-coupled polyetheramine derivatives with high selectivity and broad-spectrum antibacterial activity. Li H; Li Y; Wang Y; Liu L; Dong H; Satoh T Acta Biomater; 2022 Apr; 142():136-148. PubMed ID: 35158080 [TBL] [Abstract][Full Text] [Related]
9. Hydrophobicity-Modulated Small Antibacterial Molecule Eradicates Biofilm with Potent Efficacy against Skin Infections. Konai MM; Barman S; Issa R; MacNeil S; Adhikary U; De K; Monk PN; Haldar J ACS Infect Dis; 2020 Apr; 6(4):703-714. PubMed ID: 32058691 [TBL] [Abstract][Full Text] [Related]
10. Novel small-molecule compound YH7 inhibits the biofilm formation of Xiao Y; Wan C; Wu X; Xu Y; Chen Y; Rao L; Wang B; Shen L; Han W; Zhao H; Shi J; Zhang J; Song Z; Yu F mSphere; 2024 Jan; 9(1):e0056423. PubMed ID: 38170984 [TBL] [Abstract][Full Text] [Related]
11. Staphylococcal Bacterial Persister Cells, Biofilms, and Intracellular Infection Are Disrupted by JD1, a Membrane-Damaging Small Molecule. Dombach JL; Quintana JLJ; Detweiler CS mBio; 2021 Oct; 12(5):e0180121. PubMed ID: 34634935 [TBL] [Abstract][Full Text] [Related]
12. Antibacterial and antibiofilm potentials of vancomycin-loaded niosomal drug delivery system against methicillin-resistant Staphylococcus aureus (MRSA) infections. Hemmati J; Chiani M; Asghari B; Roshanaei G; Soleimani Asl S; Shafiei M; Arabestani MR BMC Biotechnol; 2024 Jul; 24(1):47. PubMed ID: 38978013 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and Bioactivities of New Membrane-Active Agents with Aromatic Linker: High Selectivity and Broad-Spectrum Antibacterial Activity. Chu W; Yang Y; Cai J; Kong H; Bai M; Fu X; Qin S; Zhang E ACS Infect Dis; 2019 Sep; 5(9):1535-1545. PubMed ID: 31328496 [TBL] [Abstract][Full Text] [Related]
14. Identification of N-Arylated NH125 Analogues as Rapid Eradicating Agents against MRSA Persister Cells and Potent Biofilm Killers of Gram-Positive Pathogens. Abouelhassan Y; Basak A; Yousaf H; Huigens RW Chembiochem; 2017 Feb; 18(4):352-357. PubMed ID: 27925693 [TBL] [Abstract][Full Text] [Related]
15. Antibacterial and anti-biofilm activities of thiazolidione derivatives against clinical staphylococcus strains. Liu H; Zhao Y; Zhao D; Gong T; Wu Y; Han H; Xu T; Peschel A; Han S; Qu D Emerg Microbes Infect; 2015 Jan; 4(1):e1. PubMed ID: 26038759 [TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and antibacterial activity of chalcones against MSSA and MRSA planktonic cells and biofilms. Garcia MAR; Theodoro RS; Sardi JCO; Santos MB; Ayusso GM; Pavan FR; Costa AR; Santa Cruz LM; Rosalen PL; Regasini LO Bioorg Chem; 2021 Nov; 116():105279. PubMed ID: 34509799 [TBL] [Abstract][Full Text] [Related]
18. In vitro bactericidal activity of levonadifloxacin (WCK 771) against methicillin- and quinolone-resistant Staphylococcus aureus biofilms. Tellis M; Joseph J; Khande H; Bhagwat S; Patel M J Med Microbiol; 2019 Aug; 68(8):1129-1136. PubMed ID: 31241446 [TBL] [Abstract][Full Text] [Related]
19. A recombinant fungal defensin-like peptide-P2 combats multidrug-resistant Staphylococcus aureus and biofilms. Yang N; Teng D; Mao R; Hao Y; Wang X; Wang Z; Wang X; Wang J Appl Microbiol Biotechnol; 2019 Jul; 103(13):5193-5213. PubMed ID: 31025073 [TBL] [Abstract][Full Text] [Related]
20. Novel natural osthole-inspired amphiphiles as membrane targeting antibacterials against methicillin-resistant Staphylococcus aureus (MRSA). Yang R; Xue Z; Li X; Xu T; Zhong Y; Hu S; Qin S; Guo Y Eur J Med Chem; 2024 May; 271():116449. PubMed ID: 38691893 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]